chr16-3656696-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_005223.4(DNASE1):c.379G>A(p.Gly127Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00529 in 1,613,252 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.020 ( 72 hom., cov: 31)
Exomes 𝑓: 0.0038 ( 96 hom. )
Consequence
DNASE1
NM_005223.4 missense
NM_005223.4 missense
Scores
3
6
9
Clinical Significance
Conservation
PhyloP100: 5.38
Genes affected
DNASE1 (HGNC:2956): (deoxyribonuclease 1) This gene encodes a member of the DNase family. This protein is stored in the zymogen granules of the nuclear envelope and functions by cleaving DNA in an endonucleolytic manner. At least six autosomal codominant alleles have been characterized, DNASE1*1 through DNASE1*6, and the sequence of DNASE1*2 represented in this record. Mutations in this gene have been associated with systemic lupus erythematosus (SLE), an autoimmune disease. A recombinant form of this protein is used to treat the one of the symptoms of cystic fibrosis by hydrolyzing the extracellular DNA in sputum and reducing its viscosity. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
TRAP1 (HGNC:16264): (TNF receptor associated protein 1) This gene encodes a mitochondrial chaperone protein that is member of the heat shock protein 90 (HSP90) family. The encoded protein has ATPase activity and interacts with tumor necrosis factor type I. This protein may function in regulating cellular stress responses. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0065968335).
BP6
Variant 16-3656696-G-A is Benign according to our data. Variant chr16-3656696-G-A is described in ClinVar as [Benign]. Clinvar id is 973637.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0565 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNASE1 | NM_005223.4 | c.379G>A | p.Gly127Arg | missense_variant | 5/9 | ENST00000246949.10 | NP_005214.2 | |
LOC124903631 | XR_007064954.1 | n.898C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNASE1 | ENST00000246949.10 | c.379G>A | p.Gly127Arg | missense_variant | 5/9 | 1 | NM_005223.4 | ENSP00000246949 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0196 AC: 2987AN: 152118Hom.: 73 Cov.: 31
GnomAD3 genomes
AF:
AC:
2987
AN:
152118
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00736 AC: 1835AN: 249262Hom.: 43 AF XY: 0.00612 AC XY: 825AN XY: 134884
GnomAD3 exomes
AF:
AC:
1835
AN:
249262
Hom.:
AF XY:
AC XY:
825
AN XY:
134884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00380 AC: 5555AN: 1461016Hom.: 96 Cov.: 32 AF XY: 0.00358 AC XY: 2600AN XY: 726732
GnomAD4 exome
AF:
AC:
5555
AN:
1461016
Hom.:
Cov.:
32
AF XY:
AC XY:
2600
AN XY:
726732
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0196 AC: 2985AN: 152236Hom.: 72 Cov.: 31 AF XY: 0.0195 AC XY: 1451AN XY: 74428
GnomAD4 genome
AF:
AC:
2985
AN:
152236
Hom.:
Cov.:
31
AF XY:
AC XY:
1451
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
9
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
272
ESP6500EA
AF:
AC:
30
ExAC
AF:
AC:
964
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Systemic lupus erythematosus Benign:1
Benign, no assertion criteria provided | clinical testing | UOSD Laboratory of Genetics & Genomics of Rare Diseases, Istituto Giannina Gaslini | May 21, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Benign
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of solvent accessibility (P = 0.0014);Gain of solvent accessibility (P = 0.0014);
MVP
MPC
0.032
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at